97 related articles for article (PubMed ID: 3441441)
1. In vivo activities of peptide and pseudo-peptide analogs of the C-terminal octapeptide of cholecystokinin on pancreatic secretion in the rat.
Nagain C; Rodriguez M; Martinez J; Rozé C
Peptides; 1987; 8(6):1023-8. PubMed ID: 3441441
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
3. External pancreatic secretion in the rat: supramaximal inhibition induced by the cholecystokinin octapeptide [CCK(26-33)] and analogs altered on the 28-29 bond.
Nagain C; Mendre C; Rodriguez M; Bernard C; Martinez J; Rozé C
Peptides; 1989; 10(5):1041-7. PubMed ID: 2481847
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
5. Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists.
Nagain C; Galas MC; Lignon MF; Rodriguez M; Martinez J; Rozé C
Pancreas; 1991 May; 6(3):275-81. PubMed ID: 1713671
[TBL] [Abstract][Full Text] [Related]
6. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
Lignon MF; Galas MC; Rodriguez M; Martinez J
Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321
[TBL] [Abstract][Full Text] [Related]
7. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
8. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
Bianchi BR; Miller TR; Witte DG; Lin CW
J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
[TBL] [Abstract][Full Text] [Related]
9. Large and prolonged in vivo response of pancreatic secretion to phenylethylamide and phenylethylester derivatives of Boc-[Nle28-Nle31]CCK(26-33) in the rat.
Nagain C; Lignon MF; Galas MC; Rodriguez M; Martinez J; Rozé C
Peptides; 1992; 13(6):1127-32. PubMed ID: 1494494
[TBL] [Abstract][Full Text] [Related]
10. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.
Fulcrand P; Rodriguez M; Galas MC; Lignon MF; Laur J; Aumelas A; Martinez J
Int J Pept Protein Res; 1988 Nov; 32(5):384-95. PubMed ID: 2463231
[TBL] [Abstract][Full Text] [Related]
11. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
Vinayek R; Jensen RT; Gardner JD
Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
[TBL] [Abstract][Full Text] [Related]
13. Action of pancreatic polypeptide on rat pancreatic secretion: in vivo and in vitro.
Louie DS; Williams JA; Owyang C
Am J Physiol; 1985 Oct; 249(4 Pt 1):G489-95. PubMed ID: 2413769
[TBL] [Abstract][Full Text] [Related]
14. Decreased pancreatic CCK receptor binding and CCK-stimulated amylase release in Zucker obese rats.
McLaughlin CL; Peikin SR; Baile CA
Physiol Behav; 1984 Jun; 32(6):961-5. PubMed ID: 6208569
[TBL] [Abstract][Full Text] [Related]
15. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
[TBL] [Abstract][Full Text] [Related]
16. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
[TBL] [Abstract][Full Text] [Related]
17. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
Otsuki M; Fujii M; Nakamura T; Tani S; Oka T; Yajima H; Baba S
Am J Physiol; 1987 Apr; 252(4 Pt 1):G491-8. PubMed ID: 2436486
[TBL] [Abstract][Full Text] [Related]
18. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic polypeptide inhibits amylase release by rat pancreatic acini.
Joehl RJ; DeJoseph MR
J Surg Res; 1986 Apr; 40(4):310-4. PubMed ID: 2422440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
